LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fluorescent Carbon Nanotubes Accurately Detect Bacteria and Viruses

By LabMedica International staff writers
Posted on 31 Jul 2023
Image: 3D printed model of a carbon nanotube (Photo courtesy of RUB)
Image: 3D printed model of a carbon nanotube (Photo courtesy of RUB)

An interdisciplinary research team that comprised scientists from Ruhr University Bochum (RUB, Bochum, Germany) has developed an innovative method to construct modular optical sensors capable of identifying viruses and bacteria. The team utilized fluorescent carbon nanotubes attached to a novel type of DNA anchors which serve as molecular handles. These anchor structures can be utilized to conjugate biological recognition units such as antibodies aptamers to the nanotubes, enabling interaction with bacterial or viral molecules. This interaction impacts the fluorescence of the nanotubes, causing their brightness levels to increase or decrease.

The research team utilized tubular nanosensors composed of carbon, each with a diameter of less than one nanometer. When irradiated with visible light, these nanotubes emit near-infrared light, a spectrum invisible to the human eye but ideal for optical applications due to the significant reduction of other signals within this range. Previously, the team had successfully manipulated the nanotubes' fluorescence to detect vital biomolecules. Their latest effort involved customizing carbon sensors for easy detection of various target molecules.

This breakthrough was achieved with the help of DNA structures with guanine quantum defects. This process involved linking DNA bases to the nanotube in order to introduce a defect into the nanotube's crystal structure. Consequently, the nanotubes' fluorescence underwent a quantum-level change. In addition, the defect functioned as a molecular handle, enabling the addition of a detection unit that could be adjusted to the respective target molecule to identify a specific viral or bacterial protein.

The team demonstrated the new sensor concept by targeting the SARS-CoV-2 spike protein. Researchers used aptamers that bind to the SARS-CoV-2 spike protein, following which the fluorescent sensors reliably indicated the protein's presence. Notably, the selectivity and stability of sensors featuring guanine quantum defects surpassed those of sensors without such defects, especially when in solution.

Related Links:
Ruhr University Bochum

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
ESR Analyzer
TEST1 2.0

Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more